A358570 logo

GI Innovation, Inc. Stock Price

KOSDAQ:A358570 Community·₩847.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A358570 Share Price Performance

₩13,230.00
-906.36 (-6.41%)
₩13,230.00
-906.36 (-6.41%)
Price ₩13,230.00

A358570 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
0 Rewards

GI Innovation, Inc. Key Details

₩338.1m

Revenue

₩0

Cost of Revenue

₩338.1m

Gross Profit

₩52.3b

Other Expenses

-₩52.0b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-811.18
100.00%
-15,376.98%
3.5%
View Full Analysis

About A358570

Founded
2017
Employees
n/a
CEO
Jun Ho Hong
WebsiteView website
www.gi-innovation.com

GI Innovation, Inc., a bio-venture company, engages in the research and development of protein new drugs. The company is developing GI-101/GI-102, an immune anticancer drug with novel dual fusion protein in Phase I/II clinical trial; GI-108, an metabolic immunotherapy oncology agent; and GI-301, an IgE-mediated allergy treatment designed as a fusion protein that is in Phase I clinical trial. It is also developing GI-10N, an immuno-oncology drug; GI-30N, a drug for allergic and fibrotic diseases; and GI-20N, a drug for metabolic diseases. The company was founded in 2017 and is based in Seoul, South Korea.

Recent A358570 News & Updates

GI Innovation (KOSDAQ:358570) Has Debt But No Earnings; Should You Worry?

Jan 29
GI Innovation (KOSDAQ:358570) Has Debt But No Earnings; Should You Worry?

Recent updates

No updates